20 October 2018 - Pharmaceutical companies are conducting “war games” in anticipation of Democratic proposals that would squeeze their profits.

The pharmaceutical industry, pilloried by President Trump for the last two years, is war-gaming for the possibility that its worst fear is realized: that Democrats, if they flip control of the House, find common ground with the president to rein in drug prices.

Democrats say they are determined to squeeze the industry’s prices and profits, and they have a stack of legislative proposals that could do so. Drug makers are quietly making contingency plans.

“As the midterm elections approach, a feeling of foreboding has settled over the pharmaceutical industry,” said John E. McManus, a Republican health care lobbyist whose clients include major drug companies, as well as their trade association, the Pharmaceutical Research and Manufacturers of America.

Read New York Times article